David E. Wheadon insider trades

Open-market stock purchases and sales by David E. Wheadon, Director at Vaxart, Inc, from SEC Form 4 filings since Sep 28, 2019.

Recent trades

DateStockTradeValue
Jul 16, 2026VXRT Vaxart, IncBought (not open market)—
Jul 16, 2026VXRT Vaxart, IncBought (not open market)—
May 22, 2026SHC Sotera Health CoBought (not open market)—
May 13, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Apr 30, 2026SPTX Seaport Therapeutics, IncBought (not open market)—
Jan 26, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Jan 5, 2026INDV Indivior plcBought$62.7K

Companies traded

  • VXRT Vaxart, Inc: other filings, last Jul 16, 2026
  • SHC Sotera Health Co: other filings, last May 22, 2026
  • INDV Indivior Pharmaceuticals, Inc: 1 buy, last May 13, 2026
  • SPTX Seaport Therapeutics, Inc: other filings, last Apr 30, 2026
  • KRTX Karuna Therapeutics, Inc: other filings, last Mar 18, 2024
  • CCXI ChemoCentryx, Inc: other filings, last Oct 20, 2022
  • ASRT Assertio Holdings, Inc: other filings, last Sep 28, 2020

Get free alerts when David E. Wheadon files a new trade →